Fact CheckerSign in

NCT06622941RecruitingPhase 2

Study to ONO-4538 in Patients With Rhabdoid Tumor

A Multicenter, Open-label, Uncontrolled Phase II Study to Investigate Efficacy and Safety of ONO4538 in Patients With Rhabdoid Tumor

Source: ClinicalTrials.gov · Last updated 4 Aug 2026

Brief summary (registry, in English)

Investigate the efficacy and safety of ONO-4538 for the treatment of rhabdoid Tumors

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
23 (estimated)
First submitted
30 Sept 2024
Start date
25 Nov 2024
Primary completion date
31 Jan 2029
Lead sponsor
Ono Pharmaceutical Co., Ltd.
NCT number
NCT06622941

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 23
  • From 25 Nov 2024 to the primary completion date, 31 Jan 2029
  • 14 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with a history of active concurrent malignancy or complications
  • Patients with spinal lesions expected to require radiation therapy or surgical intervention during the trial period
  • Patients with concomitant central nervous system disorders other than AT/RT that are inadequately controlled or may lead to discontinuation of the investigational drug

Who the study is looking for

  • Gender: Not specified
  • Age (at the time of consent): 1 year or older
  • Patients who are refractory or intolerant to one or more regimens of chemotherapy for rhabdoid Tumors
  • Patients with advanced or recurrent rhabdoid Tumors not eligible for curative resection

Age in the registry: 1 year to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (14)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chiba University Hospital
Coordinator of this site? Confirm its status
ChibaJapanRecruiting
National Cancer Center Hospital
Coordinator of this site? Confirm its status
Chuo KuJapanRecruiting
Kyushu University Hospital
Coordinator of this site? Confirm its status
FukuokaJapanNot yet recruiting
Fukushima Medical University Hospital
Coordinator of this site? Confirm its status
FukushimaJapanRecruiting
Hiroshima University Hospital
Coordinator of this site? Confirm its status
HiroshimaJapanRecruiting
Kanazawa University Hospital
Coordinator of this site? Confirm its status
KanazawaJapanRecruiting
Hyogo Prefectural Kobe Children's Hospital
Coordinator of this site? Confirm its status
KobeJapanRecruiting
University Hospital Kyoto Prefectural University of Medicine
Coordinator of this site? Confirm its status
KyotoJapanRecruiting
Tohoku University Hospital
Coordinator of this site? Confirm its status
MiyagiJapanRecruiting
Nagoya University Hospital
Coordinator of this site? Confirm its status
NagoyaJapanRecruiting
Niigata University Medical & Dental Hospital
Coordinator of this site? Confirm its status
NiigataJapanRecruiting
Osaka City General Hospital
Coordinator of this site? Confirm its status
OsakaJapanRecruiting
Hokkaido University Hospital
Coordinator of this site? Confirm its status
SapporoJapanRecruiting
National Center for Child Health and Development
Coordinator of this site? Confirm its status
TokyoJapanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.